✦ LIBER ✦

161 O - Very high-dose chemotherapy (VHDCT) with ematologic support in previously untreated advanced ovarian cancer (OVCA): preliminary results of a phase I-II study

✍ Scribed by P. Benedetti-panici; S. Greggl; G. Scambia; G. Salerno; M. Amoroso; G. Cutillo; G. Menichella; L. Pierelli; M.L. Foddai; B. Bizzi; S. Mancuso

Book ID: 116168437
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 135 KB
Volume: 32
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(96)84916-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Repetitive High-Dose Topotecan, Carbopla

Repetitive High-Dose Topotecan, Carboplatin, and Paclitaxel with Peripheral Blood Progenitor Cell Support in Previously Untreated Ovarian Cancer: Results of a Phase I Study

✍ H.Miles Prince; Danny Rischin; Michael Quinn; David Allen; Robert Planner; Debor 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Phase I/II study of tandem cycles of hig

Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer

✍ A. TIERSTEN; M. SELLECK; D.H. SMITH; I. WERTHEIM; E. KAUFMAN; D. HERSHMAN; L.T. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Sequential cycles of high-dose chemother

Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer

✍ Wandt, H; Birkmann, J; Denzel, Th; Schäfer, K; Schwab, G; Pilz, D; Egger, H; Bot 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB